References
- Cooper G, Willis A, Clark A, Turner R, Sim R, Reid K. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A. 1987; 84: 8628–32
- Tatemoto K, Efendic S, Mutt V, Makk G, Feitner G, Barachas J. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature (London) 1986; 324: 476–8
- Hutton J, Hansen F, Peshavaria M. Beta-Granins: 21 kDa co-secreted peptides of the insulin granule closely related to adrenal medullary chromogranin A. FEBS Lett. 1985; 188: 336–40
- Cooper G. Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease. Endocr Rev. 1994; 15: 163–201
- Hettiarachchi M, Chalkley S, Furler M, Choong Y, Heller M, Cooper G, et al. Rat amylin-(8-37) enhances insulin action and alters lipid metabolism in normal and insulin-resistant rats. Am J Physiol. 1997; 273: E859–67
- Sanchez-Margalet V, Lucas M, Goberna R. Pancreastatin: further evidence for its consideration as a regulatory peptide. J Mol Endocrinol. 1996; 16: 1–8
- Cornish J, Callon KE, Bava U, Watson M, Xu X, Lin JM, et al. Preptin, another peptide product of the pancreatic β-cell, is osteogenic in vitro and in vivo. Am J Physiol Endocrinol Metab. 2007; 292: E117–22
- Buchanan CM, Phillips ARJ, Cooper GJS. Preptin derived from proinsulin-like growth factor II (proIGF-II) is secreted from pancreatic islet β-cells and enhances insulin secretion. Biochem J. 2001; 360: 431–9
- Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. 1. Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med. 1998; 15: 539–53
- Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28: 412–9
- Kahn CR. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes. 1994; 43: 1066–84
- Taylor SI. Insulin resistance or insulin deficiency: which is the primary cause of NIDDM?. Diabetes. 1994; 43: 735–40
- Reid IR. Relationships among body mass, its components, and bone. Bone. 2002; 31: 547–55